• (Add Comment)

Marvitense 40/10/25 mg 30 tablets

123£

View analogs

Arterial hypertension (in patients who require combination therapy when mono- or dual therapy is ineffective)

Buy

Product quantities

• Sharm El Sheikh: Running out
• Hurghada: Out of stock
• Al alamein: Out of stock
• Cairo: Out of stock

Form of Release: Tablets

Product Brand: Eva Pharma
About the brand

Marvitense 40/10/25 mg 30 tablets

Composition:

One tablet contains:

• Olmesartan medoxomil - 40 mg
• Amlodipine - 10 mg
• Hydrochlorothiazide - 25 mg

Pharmacological properties:

• Olmesartan is an angiotensin II receptor blocker (sartan), reduces vascular resistance and blood pressure.
• Amlodipine is a calcium channel blocker, relaxes vascular smooth muscles, improves blood flow and reduces blood pressure.
• Hydrochlorothiazide is a thiazide diuretic, promotes the excretion of sodium and water, reducing the volume of circulating blood and lowering blood pressure.
The three components enhance each other's action, providing a persistent and pronounced decrease in blood pressure.

Indications for use:

• Arterial hypertension (in patients who require combination therapy when mono- or dual therapy is ineffective)

Method of administration and dosage:

• Recommended dose: 1 tablet once a day, preferably at the same time.
• The tablet is taken orally with a sufficient amount of water, regardless of food intake.
• The dosage is selected by the doctor depending on the patient's response to therapy and the degree of blood pressure.

Active Ingredients:

No comments yet. Be the first to write one.

Leave a Comment

Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.

I'm not a robot

Articles about the product

Videos about the product